Mary Tagliaferri Y M Abs Therapeutics, Inc. (YMAB) insider trading activity

Mary Tagliaferri is Director of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 8,155 shares of YMAB, which is worth approximately $66,137. The most recent transaction as insider was on Jun 11, 2024, when has been sold 3,495 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.16K

0% 3M change

n/a 12M change

Total Value Held $66,137

MARY TAGLIAFERRI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 11 2024	BUY Grant, award, or other acquisition	-	3,495 Added 30.0%	8,155 Common Stock
Mar 12 2024	BUY Grant, award, or other acquisition	-	4,660 Added 50.0%	4,660 Common Stock

Also insider at

ENZ

ENZO BIOCHEM INC Healthcare

Director

RYZB

RayzeBio, Inc.